| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Karin E. Bornfeldt | Q87887672 |
| P2093 | author name string | Tomohiro Nishizawa | |
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor | Q24300161 | ||
| Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects | Q24300293 | ||
| Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1 | Q24312373 | ||
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis | Q24528111 | ||
| Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice | Q24530027 | ||
| Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway | Q24539006 | ||
| HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia | Q24671941 | ||
| Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation | Q24682128 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo | Q27331780 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect | Q28211384 | ||
| 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia | Q28286230 | ||
| Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes | Q28299458 | ||
| Glucose transporters in the 21st Century | Q29302398 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| HIF-1alpha is essential for myeloid cell-mediated inflammation | Q29617581 | ||
| Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation | Q30431948 | ||
| Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages | Q30439419 | ||
| Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis | Q30440695 | ||
| Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice | Q30444108 | ||
| Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study | Q44680472 | ||
| Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation | Q44752269 | ||
| Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
| Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. | Q45983837 | ||
| Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake | Q46046020 | ||
| ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo | Q46888991 | ||
| Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells | Q71800436 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| [Quantification of macrophages and granulocytes at the joint cartilage-pannus junction in rheumatoid arthritis] | Q73223739 | ||
| Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation | Q74408513 | ||
| Evidence of hypoxic areas within the arterial wall in vivo | Q77297609 | ||
| Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy | Q77297659 | ||
| Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation | Q84291714 | ||
| Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study | Q30789138 | ||
| PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. | Q31879172 | ||
| Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. | Q33662075 | ||
| Macrophage responses to hypoxia: relevance to disease mechanisms. | Q33805936 | ||
| Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha | Q33925239 | ||
| Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). | Q33932860 | ||
| A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism | Q34144698 | ||
| Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways | Q34355379 | ||
| Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury | Q34459819 | ||
| The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits | Q36261543 | ||
| Macrophage polarization comes of age. | Q36287066 | ||
| Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? | Q36775094 | ||
| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes | Q36842628 | ||
| Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. | Q36883079 | ||
| Hypoxia, glucose metabolism and the Warburg's effect. | Q36895405 | ||
| Distinct monocyte gene-expression profiles in autoimmune diabetes | Q36906389 | ||
| Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia | Q36916418 | ||
| Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). | Q36928042 | ||
| The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models | Q37282249 | ||
| Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries | Q37316651 | ||
| Oxygen sensors at the crossroad of metabolism | Q37360663 | ||
| Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells | Q37405753 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| FDG PET imaging and cardiovascular inflammation. | Q37800428 | ||
| Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. | Q39823921 | ||
| Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages | Q40234862 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages | Q41544657 | ||
| Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages | Q41661978 | ||
| Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages | Q41822196 | ||
| Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture | Q41967685 | ||
| Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice | Q42489998 | ||
| Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages | Q42523070 | ||
| GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions | Q42577780 | ||
| Severe hypoglycemia and risks of vascular events and death | Q42868535 | ||
| Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography | Q43198454 | ||
| Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin | Q43606088 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile | Q44168286 | ||
| Hypoxia, HIF1 and glucose metabolism in the solid tumour | Q44633634 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 555-563 | |
| P577 | publication date | 2011-06-17 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Diabetic vascular disease and the potential role of macrophage glucose metabolism | |
| P478 | volume | 44 |
| Q92344772 | Association between Beta2-Adrenergic Receptor Agonists and the Risk of Vascular Complications in Diabetic Patients: A Population-Based Cohort Study |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q33758111 | Cytokine profiling of young overweight and obese female African American adults with prediabetes |
| Q54937504 | Effect of N-Acetylcysteine on Dyslipidemia and Carbohydrate Metabolism in STZ-Induced Diabetic Rats. |
| Q36937435 | High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells |
| Q91782613 | Lung volume dependence of respiratory function in rodent models of diabetes mellitus |
| Q58121145 | New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis |
| Q33612986 | Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis |
Search more.